RONA JEFFREY A (Chief Business Officer) sold 8.8% of their position (8.54K shares) of OVID THERAPEUTICS INC. on the open market
Open‑market sale worth $12.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/2/2026ACC: 0001311404-26-000002
Officer· Chief Business Officer
Since Sep 2020
+468.33K
Net shares
Net buyer
$12.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
476.88K acquired · 8.54K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−8.54K
Price / share
$1.45
Trade value
$12.38K
% of position
8.8%
2/23/2026
96.73K→88.19K
Common Stock
Direct
Shares
+68.13K
Price / share
—
Trade value
—
% of position
77.2%
2/26/2026
88.19K→156.31K
Total
Net shares
+59.58K
Net value
-$12.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2026 | S · Sale | −8.54K | $1.45 | $12.38K | 8.8% | 96.73K | 88.19K |
| Common Stock Direct | 2/26/2026 | A · Award | +68.13K | — | — | 77.2% | 88.19K | 156.31K |
| Total | +59.58K | -$12.38K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
408.75K shares
Shares
+408.75K
Strike price
1.65
Held after
408.75K
Exercisable
—
2/26/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock408.75K shares | 2/26/2026 | A · Award | +408.75K | 1.65 | — | 408.75K |